StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
CVS Health (CVS) PT Raised to $115 at Cantor Fitzgerald
November 3, 2021 1:33 PM
Cantor Fitzgerald analyst Steven Halper raised the price target on CVS Health (NYSE: CVS) to $115.00 (from $95.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
CVS Health (CVS) call put ratio 8.7 calls to 1 put as shares rally 5.8%
November 3, 2021 10:57 AM
CVS Health (CVS) Announces Availability of Pfizer-BioNTech COVID-19 Vaccine to Children Aged 5-11
November 3, 2021 10:01 AM
CVS Health Announces Availability of Pfizer-BioNTech COVID-19 Pediatric Vaccine to Children Ages Five to 11
November 3, 2021 10:00 AM
CVS Health sees 2022 profit meeting Street estimates as COVID-19 costs subside
November 3, 2021 6:47 AM
Form 10-Q CVS HEALTH Corp For: Sep 30
November 3, 2021 6:47 AM
Form 8-K CVS HEALTH Corp For: Nov 03
November 3, 2021 6:44 AM
CVS Health Reports Strong Third Quarter Results
November 3, 2021 6:41 AM
CVS Health (CVS) Tops Q3 EPS by 20c, Lifts FY EPS Guidance
November 3, 2021 6:37 AM
$10 Million Commitment Made to The American Diabetes Association by CVS Health to Reach Five Million Patients and Transform Health Outcomes
November 2, 2021 8:27 AM
